The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer.
about
The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferationPeripheral opioid antagonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivoGrowth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancerGalectin-1 and its involvement in hepatocellular carcinoma aggressivenessDiabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a reviewInhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors.Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function.Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis.Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancerInternalization of the opioid growth factor, [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferationSynergistic effect of methionine encephalin (MENK) combined with pidotimod(PTD) on the maturation of murine dendritic cells (DCs)Opioid growth factor - opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer.Under-expression of the opioid growth factor receptor promotes progression of human ovarian cancer.Low-dose naltrexone targets the opioid growth factor-opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model.Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin.Regulation of cell proliferation by the opioid growth factor receptor is dependent on karyopherin beta and Ran for nucleocytoplasmic trafficking.Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers.Passive diffusion of naltrexone into human and animal cells and upregulation of cell proliferation.Dependence on nuclear localization signals of the opioid growth factor receptor in the regulation of cell proliferation.Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment.Featured Article: Nuclear export of opioid growth factor receptor is CRM1 dependentIntegrated proteomic and transcriptomic analysis revealslong noncoding RNA HOTAIR promotes hepatocellular carcinoma cell proliferation by regulating opioid growth factor receptor (OGFr).Targeted overexpression of OGFr in epithelium of transgenic mice suppresses cell proliferation and impairs full-thickness wound closure.Targeting the opioid growth factor: opioid growth factor receptor axis for treatment of human ovarian cancer.Modulation of the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: novel therapies for squamous cell carcinoma of the head and neck.The novel mechanism of anticancer effect on gastric cancer through inducing G0/G1 cell cycle arrest and caspase-dependent apoptosis in vitro and in vivo by methionine enkephalin
P2860
Q24654924-741EAAB4-0B16-4628-A3FE-D00F6AA8BE90Q28545949-2D55F9B8-B3FC-46FA-A80C-288A929ADB3AQ33511045-DDABAC6E-569C-48F6-A70A-62C1E1239AFCQ33686632-DB18C410-8843-4798-A530-C570B96F2DC5Q33692511-F4B0DD14-E3EF-4EB8-9604-655DE958612EQ33781293-E3DF986D-EC5D-450A-8301-3B4C94AA24B7Q34624683-B7090B27-EDEC-4088-9CFD-3B21D1A9CCCFQ34778672-E667981C-7923-4A90-AFD2-C25BEA97DBCFQ34965037-E17A84CA-A173-4AC7-971A-D31EA5A902E1Q35598669-8C188B50-BC1F-4E7E-B73C-F5C3EC584C0DQ36477169-42D93020-56D5-41C2-A61C-236B6272A738Q37174499-C6F1D5F6-4166-4DD8-A9EF-D0CF4AF95FC9Q37521866-B935B44E-1ADD-4025-BBC3-F6D9914B718AQ39114818-01730701-30F2-460C-90E0-E39A093BCDBEQ39397468-91C8C1A7-3F39-46D8-A533-E6A15CED20B7Q39496812-7822F9F2-58BE-4D5A-853C-3A7DC7BA7B45Q39522079-8CD5ED15-981E-4C93-9F92-FE2093D015B5Q39668111-52B63786-B727-4E36-A0B7-78B390CAD92BQ39813287-72C69189-0696-475A-8F60-19B70EB94778Q39824856-298C1D54-7F7C-4D8A-AE85-95D65718C83FQ39879490-DAD26E0F-8F6A-4CE4-903F-5A10E0F02E3FQ40262668-D7C56BAC-4FC8-415C-A0F3-B1735A11EEC3Q41848369-A58012E1-7D96-4F58-A36D-54A0B5A59DF9Q42778320-C9573213-92E5-4BDE-B653-CAB4BFC512EEQ44031670-2D41C70C-321F-41DF-8964-7C120F1B3FFBQ44340325-BC0D3A4D-B65E-44F9-AC59-ED1518138CF8Q44350786-7E7680BA-5192-410D-B3F1-4BF100D4CBABQ58694707-68FDF9EA-204B-4C5B-9DAC-A52D16296450
P2860
The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
The opioid growth factor (OGF) ...... inhibit head and neck cancer.
@ast
The opioid growth factor (OGF) ...... inhibit head and neck cancer.
@en
type
label
The opioid growth factor (OGF) ...... inhibit head and neck cancer.
@ast
The opioid growth factor (OGF) ...... inhibit head and neck cancer.
@en
prefLabel
The opioid growth factor (OGF) ...... inhibit head and neck cancer.
@ast
The opioid growth factor (OGF) ...... inhibit head and neck cancer.
@en
P2093
P1433
P1476
The opioid growth factor (OGF) ...... inhibit head and neck cancer.
@en
P2093
Ian S Zagon
Patricia J McLaughlin
P304
10511-10518
P356
10.1158/0008-5472.CAN-07-1922
P407
P577
2007-11-01T00:00:00Z